Items where authors include "Larkin, J."

Article

Abed Abud, A., Abi, B., Acciarri, R. et al. (1369 more authors) (2025) The track-length extension fitting algorithm for energy measurement of interacting particles in liquid argon TPCs and its performance with ProtoDUNE-SP data. Journal of Instrumentation, 20 (02). P02021. ISSN 1748-0221

Abratenko, P., Abrego-Martinez, N., Aduszkiewicz, A. et al. (178 more authors) (2025) Angular dependent measurement of electron-ion recombination in liquid argon for ionization calorimetry in the ICARUS liquid argon time projection chamber. Journal of Instrumentation, 20. P01033.

Abratenko, P., Abrego-Martinez, N., Aduszkiewicz, A. et al. (178 more authors) (2025) Calibration and simulation of ionization signal and electronics noise in the ICARUS liquid argon time projection chamber. Journal of Instrumentation, 20. P01032.

Abed Abud, A., Abi, B., Acciarri, R. et al. (1368 more authors) (2024) DUNE Phase II: scientific opportunities, detector concepts, technological solutions. Journal of Instrumentation, 19 (12). P12005. ISSN 1748-0221

Abud, A.A., Abi, B. orcid.org/0000-0001-7036-9645, Acciarri, R. et al. (1363 more authors) (2024) First measurement of the total inelastic cross section of positively charged kaons on argon at energies between 5.0 and 7.5 GeV. Physical Review D, 110. 092011. ISSN 2470-0010

Abratenko, P., Acciarri, R., Adams, C. et al. (179 more authors) (2024) Scintillation light in SBND: simulation, reconstruction, and expected performance of the photon detection system. The European Physical Journal C, 84 (10). 1046. ISSN 1434-6044

Abed Abud, A., Abi, B., Acciarri, R. et al. (1359 more authors) (2024) Performance of a modular ton-scale pixel-readout liquid argon time projection chamber. Instruments, 8 (3). 41. ISSN 2410-390X

Abed Abud, A., Abi, B., Acciarri, R. et al. (1318 more authors) (2024) Doping liquid argon with xenon in ProtoDUNE single-phase: effects on scintillation light. Journal of Instrumentation, 19. P08005. ISSN 1748-0221

Abed Abud, A., Abi, B., Acciarri, R. et al. (1356 more authors) (2024) The DUNE far detector vertical drift technology. Technical design report. Journal of Instrumentation, 19. T08004.

Culliford, R. orcid.org/0000-0003-4534-9241, Lawrence, S.E.D., Mills, C. orcid.org/0000-0002-4755-7549 et al. (40 more authors) (2024) Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma. Nature Communications, 15. 5935. ISSN 2041-1723

Sacco, J.J., Jackson, R., Corrie, P. et al. (18 more authors) (2024) A three-arm randomised phase II study of the MEK inhibitor selumetinib alone or in combination with paclitaxel in metastatic uveal melanoma. European Journal of Cancer, 202. 114009. ISSN 0959-8049

Abud, A.A., Abi, B., Acciarri, R. et al. (1224 more authors) (2023) Reconstruction of interactions in the ProtoDUNE-SP detector with Pandora. The European Physical Journal C, 83. 618.

Abed Abud, A., Abi, B., Acciarri, R. et al. (1315 more authors) (2023) Impact of cross-section uncertainties on supernova neutrino spectral parameter fitting in the Deep Underground Neutrino Experiment. Physical Review D, 107 (11). 112012. ISSN 2470-0010

Abud, A.A., Abi, B., Acciarri, R. et al. (1256 more authors) (2023) Identification and reconstruction of low-energy electrons in the ProtoDUNE-SP detector. Physical Review D, 107 (9). 092012. ISSN 2470-0010

Abed Abud, A., Abi, B., Acciarri, R. et al. (1303 more authors) (2023) Highly-parallelized simulation of a pixelated LArTPC on a GPU. Journal of Instrumentation, 18 (04). P04034. ISSN 1748-0221

Ng, K.W., Boumelha, J., Enfield, K.S.S. orcid.org/0000-0002-4551-6073 et al. (328 more authors) (2023) Antibodies against endogenous retroviruses promote lung cancer immunotherapy. Nature, 616. pp. 563-573. ISSN 0028-0836

Brown, J.E. orcid.org/0000-0003-4960-3032, Royle, K.-L., Gregory, W. et al. (96 more authors) (2023) Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial. The Lancet Oncology, 24 (3). pp. 213-227. ISSN 1470-2045

Eisen, T., Frangou, E., Oza, B. et al. (22 more authors) (2020) Adjuvant Sorafenib for Renal Cell Carcinoma at Intermediate or High Risk of Relapse: Results From the SORCE Randomized Phase III Intergroup Trial. Journal of Clinical Oncology, 38 (34). pp. 4064-4075. ISSN 0732-183X

Arce Vargas, F., Furness, A.J.S., Litchfield, K. et al. (249 more authors) (2018) Fc effector function contributes to the activity of human anti-CTLA-4 antibodies. Cancer Cell, 33 (4). 649-663.e4. ISSN 1535-6108

Powles, T., Brown, J., Larkin, J. et al. (17 more authors) (2016) A randomized, double-blind phase II study evaluating cediranib versus cediranib and saracatinib in patients with relapsed metastatic clear-cell renal cancer (COSAK). Annals of Oncology, 27 (5). pp. 880-886. ISSN 0923-7534

Ahmad, S.S., Qian, W., Ellis, S. et al. (26 more authors) (2015) Ipilimumab in the real world: the UK expanded access programme experience in previously treated advanced melanoma patients. Melanoma Research, 25 (5). pp. 432-442. ISSN 0960-8931